Cargando…
Bacillus subtilis IolQ (DegA) is a transcriptional repressor of iolX encoding NAD(+)-dependent scyllo-inositol dehydrogenase
BACKGROUND: Bacillus subtilis is able to utilize at least three inositol stereoisomers as carbon sources, myo-, scyllo-, and D-chiro-inositol (MI, SI, and DCI, respectively). NAD(+)-dependent SI dehydrogenase responsible for SI catabolism is encoded by iolX. Even in the absence of functional iolX, t...
Autores principales: | Kang, Dong-Min, Michon, Christophe, Morinaga, Tetsuro, Tanaka, Kosei, Takenaka, Shinji, Ishikawa, Shu, Yoshida, Ken-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504672/ https://www.ncbi.nlm.nih.gov/pubmed/28693424 http://dx.doi.org/10.1186/s12866-017-1065-8 |
Ejemplares similares
-
A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease
por: Yamaoka, Masaru, et al.
Publicado: (2011) -
A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production
por: Tanaka, Kosei, et al.
Publicado: (2017) -
An improved Bacillus subtilis cell factory for producing scyllo-inositol, a promising therapeutic agent for Alzheimer’s disease
por: Tanaka, Kosei, et al.
Publicado: (2013) -
High binding affinity of repressor IolR avoids costs of untimely induction of myo-inositol utilization by Salmonella Typhimurium
por: Hellinckx, Jessica, et al.
Publicado: (2017) -
Comparison of Different IOL Types in the Flanged IOL Fixation Technique
por: Miura, Yusaku, et al.
Publicado: (2020)